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The pattern of covalent crosslinking between human q-macroglobulin (%M) and chymotrypsin has been 
investigated by chromatography and polyacrylamide gel electrophoresis in denaturing medium. Reaction 
with a single mol of chymotrypsin per mol %M results in the formation of a 95% covalent 1: 1 chymotrypsin- 
$M complex and in the proteolytic cleavage of both 180 kDa monomers in one $M subunit. Proteolytic 
cleavage in the other %M subunit requires the presence of a second mol of chymotrypsin; part (20%) of 
the protease in the 2: 1 chymotrypsin-$M complex thus formed appears to be non-covalently bound to the 
%M chains. Covalent binding is abolished when the reaction of CQM with the protease is carried out in 
the presence of hydroxylamine. A single mol of the protease is then able to cleave all four 180 kDa 
monomers in %M. 
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1. INTRODUCTION 
Human LY~M is a tetramer of four identical 
subunits formed by the non-covalent association 
of two disulfide-bonded pairs [l-3]. Each subunit 
has two functional regions. The first is the site of 
limited proteolysis by bound proteases (bait 
region) and is located near the centre of the subunit 
peptide chains [l], the second region is a reactive 
group, namely a thiol ester [4,5], located 200 
amino acid residues from the first. The inhibition 
reaction has been proposed to occur via a ‘trap’ 
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mechanism [6] initiated by a limited proteolysis of 
the a2M bait region followed by a conformational 
change during which the disruption of the thiol 
ester bonds occurs, leading to the appearance of 
activated glutamic acid residues which can 
covalently react with the entrapped protease [7]. In 
the present study, we show that the covalent 
binding of chymotrypsin to CQM in a 1: 1 molar 
ratio induces the transformation of only one of the 
two functional domains [8] of the inhibitor, 
whereas a non-covalent binding mode of the pro- 
tease is able to transform the whole cv2M molecule, 
as estimated by the extent of proteolytic cleavage. 
2. MATERIALS AND METHODS 
2.1. Materials 
Human a2M was prepared by Zn2+ affinity 
chromatography [9] and filtered on an ACA 22 
column as a final step of purification. Bovine pan- 
creatic chymotrypsin was purified by chroma- 
tography on a DEAE-trisacryl column equilibrated 
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with 10 mM Tris-HCl, pH 8.0, and labelled by 
fluorescein isothiocyanate as in [lo]. 
2.2. Methods 
All enzymatic and spectrophotometric mea- 
surements were made in 20 mM Hepes, 50 mM 
NaCl, pH 7.10. 
Chymotrypsin activity was evaluated using the 
chromogenic substrate Sue-Ala-Ala-Pro-Phe-pNA 
(Serva). 
Substitution of free cystein sulfhydryl groups in 
chymotrypsin-cuzM complexes by I-AEDns was 
achieved as in [lo]. 
CYZM and chymotrypsin were radioiodinated us- 
ing the Bolton Hunter reagent (NEN) as follows: 
proteins at 5 mg/ml in 80 mM Hepes, pH 7.8, 
were added to about 0.5 mCi of the reagent and 
left at room temperature for 10 min. The 1251- 
labelled proteins were then isolated by Sephadex 
G-25 filtration. 
The estimation of covalently bound chymotryp- 
sin was performed using FITC-chymotrypsin. 
Protease-cu2M complexes were filtered on a 
Sephacryl S-300 column under denaturing condi- 
tions and the peak area corresponding to FITC- 
labelled protease comigrating with high-M, 
fragments of CQM estimated [l 11. 
Polyacrylamide gel electrophoresis was perform- 
ed in 5% acrylamide, pH 8.8, 0.05% SDS. 
Samples were prepared by adding a given amount 
of chymotrypsin to 60~1 of 3 PM 0~2M. After 
10 min of incubation, 5 yl of diisopropyl- 
fluorophosphate (0.5 M in dioxane) were added, 
followed 10 min later by 5 ~1 of 10% SDS, and 5 ~1 
mercaptoethanol. The mixtures were heated to 
45°C for 1 h and submitted to electrophoresis. 
After staining with Coomassie blue, the gels were 
stained and cut in 2 mm slices and the radioactivity 
of each slice measured in a gamma counter. 
Fluorescence was measured using a Kontron 
SFM-25 fluorimeter equipped with a thermostated 
cell holder and polarization accessories. Energy 
transfer efficiencies within the a2M-protease com- 
plexes [ 11,161 were determined as E = 1 - !-%A/@% 
from the fluorescence quantum yield of the com- 
plex containing the donor only (@n = I-AEDns- 
labelled ~zM + unlabelled chymotrypsin) and of 
the complex containing both the donor and accep- 
tor dyes (@-%A = I-AEDns-labelled 0~2M + FITC- 
labelled chymotrypsin). The polarization values of 
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the FITC-labelled conjugates were determined 
with excitation at 475 nm and emission at 520 nm. 
Electron microscopy was performed as in [12]. 
3. RESULTS 
3.1. Influence of the covalent and non-covalent 
binding mode of chymotrypsin to 44 on the 
extent of bait region cleavage 
Fig.1 shows the electrophoretic pattern of 
chymotrypsin-azM complexes formed at different 
protease_crzM molar ratios. The two major bands 
observed correspond to the well known [13] con- 
version of the 180 kDa chains (C) of LY~M into 
90 kDa fragments (F) by limited proteolysis. 
Fainter bands also appeared in two pairs (A + B) 
and (D + E) at apparent molecular masses of 
about 200 and 100 kDa, respectively. These bands 
are found to contain 1251-chymotrypsin a d can be 
then considered as covalent conjugates of protease 
fragments generated by the reduction of disulfide 
bridges [14] within the chymotrypsin molecule with 
the 180 and 90 kDa peptide chains of (YzM. 
When 1251-labelled CYZM is used, the bulk of the 
radioactivity is found to co-migrate with bands (C) 
and (F) whose relative amounts allow one to deter- 
mine the extent of proteolytic cleavage of the 
180 kDa chains. As shown in table 1, a quite linear 
relation between the extent of bait region cleavage 
and the chymotrypsin-a2M ratio in the molar range 
O-2 proteases per CYZM is found, i.e. two mol of 
chymotrypsin are necessary to cleave the four pep- 
tide chains of a2M. 
&zM is now allowed to react with chymotrypsin 
in the presence of 40 mM hydroxylamine. This 
primary amine, at this concentration, does not in- 
activate CQM and prevents covalent bond forma- 
tion between the protease and the inhibitor [15] as 
does the commonly used methylamine [7]. Indeed, 
the faint bands disappear (fig.1). Furthermore, a 
single chymotrypsin molecule is then able to bring 
to completion the 180 kDa proteolysis (table 1). 
In an attempt to correlate the extent of bait 
region cleavage with the binding mode of the pro- 
tease to the inhibitor, different LuzM-chymatrypsin 
complexes were filtered under denaturing condi- 
tions. In amine-free buffer the yield of covalent 
binding is 95% and 85% for the 1: 1 and 1: 2 a2M- 
protease complexes, respectively. In contrast, 
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Fig. 1. Polyacrylamide gel electrophoresis of chymotrypsin-az-macroglobulin conjugates under denaturing and reducing 
conditions. Lanes l-5 show the pattern obtained with none (l), 0.5 (2), 1.0 (3), 1.5 (4) and 2.0 (5) equivalents of 
chymotrypsin per cuzM; lanes 6 and 7 show the effect of hydroxylamine (40 mM final concentration) on the 
chymotrypsin-cu2M interaction using molar ratios of 0.6 and 1.0, respectively. 
covalent crosslinking is close to zero when the 
complexes are prepared in the presence of 40 mM 
hydroxylamine. 
These data suggest that n intramolecular ather 
than an intermolecular proteolysis of azM by a 
non-covalently bound chymotrypsin molecule may 
be considered. We then investigated the behaviour 
of a non-covalent 1: 1 chymotrypsin-cuzM complex 
in the presence of a large excess of native LYZM. 
3.2. The cleavage of the four aMpeptide chains 
by a single non-covalently bound chymo- 
trypsin proceeds by an intramolecular 
proteolysis 
In order to evidence that chymotrypsin, non- 
covalently bound to LYZM, is not able to proteolyse 
a2M molecules other than those to which the pro- 
tease is initially bound, experiments using energy 
transfer measurements were undertaken. For this 
purpose, FITC-labelled chymotrypsin (1 f 0.1 
label per chymotrypsin) is reacted with CQM in the 
presence of 40 mM hydroxylamine and I-AEDns. 
The protease induces the appearance of the azM 
free thiol groups which then react with the 
sulfhydryl reagent [16]. The doubly labelled com- 
plex is then isolated by Sephadex G-25 filtration 
and the energy transfer efficiency value E deter- 
mined from fluorescence quenching measurement 
of I-AEDns by FITC-labelled protease [11,161. E is 
found to be 0.62. An aliquot is prepared in the 
same way in amine-free buffer and is used as a 
control. 
Now, a lo-fold molar excess of native r2?-(y2M 
is added and the mixture incubated at 37°C for 
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Table 1 
Extent of bait region cleavage in chymotrypsin- 
[1251]ruz-macroglobulin complexes 
Chymotrypsin/azM 
(mol/mol) 
% bait region cleavagea 
In hydroxyl- In the presence 
amine free of 40 mM 
buffer hydroxylamine 
0.25 10 27 
0.5 27 53 
0.75 35 78 
1.0 53 100 
1.5 78 - 
2.0 98 - 
a The radioactivity recovered in each h4, 180000 and 
90000 electrophoretic band was used to estimate the 070 
of A4,180000 disappearance; 100% = four bait regions 
per mol; the values are the average of four 
determinations 
8 h. Every 30 min, aliquots are set apart for quen- 
ching and 90 kDa fragment appearance 
measurements. A displacement of the labelled pro- 
tease from its initial complex by native LYZM to 
form a new complex should (i) decrease the 
transfer efficiency, the newly generated -SH 
groups of azM being not labelled, (ii) increase the 
90 kDa fragment generation. On the other hand, 
an increase in the extent of 180 kDa chain cleavage 
without modification of the transfer efficiency 
value could result from proteolysis of LY~M 
subunits by cuzM-bound chymotrypsin. 
It is observed that the initial value of E as well 
as the amount of 180 kDa chains are not 
significantly affected during the incubation time. 
However, a 10% decrease of the E value is ob- 
served and could be correlated to a further pro- 
teolysis of the initial complex, as suggested by the 
concomitant disappearance of 90 kDa fragments 
giving lower molecular mass products. 
4. DISCUSSION 
In the present study, the reaction of chymotryp- 
sin with (YZM has been characterized by quan- 
titating the extent of cw2M peptide chain cleavage 
with respect to the binding mode of the protease. 
The data describing the covalent binding mode of 
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chymotrypsin with CQM are consistent with a se- 
quential mechanism in which each functional unit 
of the (YZM molecule is successively altered as 
already observed with other proteases [17-191. But 
the non-covalent binding of chymotrypsin induces 
the modification of the two protease-binding sites 
of the inhibitor. 
It can be pointed out that the non-covalently 
bound chymotrypsin molecule is always ‘trapped’ 
within the azM molecule as suggested by the 
following observations. Indeed, whatever the 
binding mode of chymotrypsin to azM (1: 1 molar 
ratio), we found that (i) under the electron 
microscope all complexes display the same cyrillic 
J type X-shape, (ii) the catalytic properties of the 
bound proteases towards Sue-Alaz-Pro-Phe-pNA 
are always lowered to about 65% with respect to 
the free enzyme, (iii) the values of fluorescence 
quenching (25%) and red shift (3 nm) of the FITC- 
labelled protease measured upon a2M fixation are 
similar; furthermore, energy transfer efficiencies 
from the labelled -SH groups of cv2M towards the 
labelled protease are not significantly different, 
thus supporting the idea that the covalent and non- 
covalent protease-binding sites of cv2M have a quite 
similar localization in the complexes, (iv) the 
polarization values of the FITC-labelled 
chymotrypsin present the same variations upon 
LY~M fixation 0, = 0.17 and 0.35 for the free and 
LuzM-bound enzyme). 
In conclusion, the alteration of the two protease- 
binding sites of CYZM by a single molecule of 
chymotrypsin is compatible with the WM structure 
as observed by electron microscopy [12] and im- 
plies a close localization of the two protease- 
binding sites of a2M [lo] on each site of the bin- 
ding surface of the LXY~M subunits [20]. Our results 
also support a recently proposed model of the 
protease_cuzM complex [21] which suggests a par- 
tial occupancy by a single protease molecule of the 
two protease binding sites of WM. 
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